QC Healthcare Partners With Sanguina for AI Blood Health Screening

Sep 22, 2026
QC Healthcare will add Sanguina's AI fingernail analysis technology to its pediatric and adult telehealth platforms for blood health screening and monitoring.

QC Healthcare announced in a press release a collaboration with Sanguina to integrate its AI based fingernail analysis technology into the My Pediatric Doctor and My Adult Doctor platforms. The initial deployment will support pediatric and adult telehealth services available 24 hours a day.

The patented technology analyzes fingernail videos to screen for and track anemia, circulation issues, and other blood health risks. QC Healthcare also plans to use it in the My VA Doctor and My Oncology Doctor platforms.

Sanguina's Circulation Score is a screening and monitoring tool, not a diagnosis or substitute for laboratory testing, physical examinations, or emergency evaluation. The companies will also work on clinical validation, real world evidence, and clinical trial recruitment and coordination.

We hope you enjoyed this article

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.